Encompass Health financials
$124.02+0.45%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.60B | $1.59B | $1.54B | $1.48B | $1.46B | $1.46B | $1.41B | $1.35B | $1.30B | $1.32B | $1.25B | $1.21B |
| Gross profit | $1.60B | $1.59B | $1.54B | $1.48B | $1.46B | $1.46B | $1.41B | $1.35B | $1.30B | $1.32B | $1.25B | $1.21B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $288.4M | $301.6M | $283.4M | $243.6M | $259.1M | $267.0M | $232.3M | $209.1M | $215.6M | $207.5M | $189.9M | $179.4M |
| Net income | $153.9M | $194.5M | $144.6M | $126.5M | $142.1M | $151.5M | $118.1M | $108.2M | $114.1M | $112.5M | $87.0M | $84.7M |
| Net margin | 9.6% | 12.3% | 9.4% | 8.6% | 9.7% | 10.4% | 8.4% | 8.0% | 8.8% | 8.5% | 7.0% | 7.0% |
| Diluted EPS | $1.54 | $1.93 | $1.42 | $1.24 | $1.39 | $1.48 | $1.15 | $1.06 | $1.12 | $1.10 | $0.85 | $0.84 |
| EBITDA | $469.2M | $388.9M | $369.8M | $326.0M | $418.9M | $346.2M | $310.3M | $287.5M | $288.5M | $277.8M | $189.9M | $246.7M |
| Operating cash flow | $282.6M | $313.1M | $346.0M | $270.8M | $270.2M | $288.6M | $278.8M | $267.8M | $217.4M | $238.8M | $201.0M | $215.2M |
| Free cash flow | $62.3M | $150.7M | $116.7M | $83.7M | $113.3M | $125.5M | $80.1M | $120.3M | $60.5M | $99.4M | -$10.7M | $65.5M |
| Diluted shares | 100.0M | 100.6M | 102.1M | 102.3M | 102.3M | 102.1M | 102.5M | 102.1M | 102.0M | 102.2M | 101.8M | 101.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $107.7M | $110.5M | $72.2M | $48.7M | $99.1M | $95.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.63B | $2.57B | $2.49B | $2.43B | $2.46B | $2.47B |
| Total assets | $7.46B | $7.31B | $7.09B | $6.87B | $6.79B | $6.64B |
| Total liabilities | $4.00B | $3.95B | $3.81B | $3.68B | $3.70B | $3.70B |
| Shareholders' equity | $3.46B | $3.31B | $3.28B | $3.13B | $3.03B | $2.88B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology